HOME >> MEDICINE >> NEWS
Biochemical Marker Targets Brain Injury Leading To Movement Problems After Stroke

DALLAS, May 7 -- Researchers have used biochemical markers for the first time to locate the brain injury that is associated with loss of movement in individuals who have had a stroke. The study is reported in this month's Stroke: Journal of the American Heart Association.

The findings are considered significant because scientists are now able to pinpoint an area of the brain associated with loss of movement resulting from a stroke. Identifying the location of brain cell damage provides scientists with a target site for designing treatments that could halt or slow the progression of such cell damage in stroke patients.

To locate this brain region, the scientists measured levels of a biochemical substance found almost exclusively in adult brain cells. They used magnetic resonance spectroscopy (MRS), a technique for quantitative measurements of the concentrations of biochemical substances, to measure levels of N-acetylaspartate (NAA) in various areas of the brain.

The role of NAA in the brain is unclear, but studies suggest it may be associated with protein building and the transmission of signals between nerve cells. The researchers found reduced concentrations of NAA in a particular brain region were linked with weakness in patients with stroke. This region, known as the internal capsule, has nerve pathways that transmit signals to and from the brain.

"When combined with magnetic resonance imaging (MRI), a visualization method for detecting clots or blockages in the brain that trigger most strokes, MRS provides scientists with a panoramic, interactive view of both site and function within the nervous system," says lead researcher Sarah T. Pendlebury, MRCP, at the Centre for Functional Magnetic Resonance of the Brain, John Radcliffe Hospital, Oxford, United Kingdom.

George Hademenos, Ph.D., staff scientist with the American Heart Association, notes that these findings suggest that the injured brain cells within the internal capsule could be
'"/>

Contact: Florence Antoine
florencea@heart.org
214-706-1135
American Heart Association
6-May-1999


Page: 1 2

Related medicine news :

1. Biochemical marker aids prognosis in liver transplant patients
2. Biochemical storm following brain trauma, an important factor in treatment
3. Researchers Identify Biochemically Distinct Pain Phenomena, Conclude Better Pain Relief At Lower Morphine Doses Is Possible
4. Persistently abnormal liver function tests: Marker of occult hepatitis C?
5. A Genetic Marker Of Panic Disorder
6. University Of Pittsburgh Cancer Institute Defines First Immunologic Markers Of Interferon Effectiveness Against Melanoma
7. Biological Markers Found That Correlate To Esophageal Cancer Treatment Success
8. Marker Found For The Most Malignant Brain Tumors
9. Campaign Targets Oral Complications Of Cancer Treatment
10. Campaign Targets Oral Complications Of Cancer Treatment
11. New Radiation Procedure Targets Liver Malignancies

Post Your Comments:
(Date:5/19/2013)... Buenos Aires, Argentina: Yoga classes ( clases de Yoga ... by the Sivananda Yoga Vedanta Center. The center ... Norte). Classes are 90 minutes and are offered all ... a calm environment, allowing visitors to enjoy the benefits ... among others. , The Yoga classes follow the following ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 The legal ... website YazSideEffects.com in a concerted effort to connect women ... combination birth control drugs Yaz, Yasmin & Ocella with ... wealth of information on the notorious birth control drugs ... Bayer Pharmaceuticals. , Yaz, Yasmin & Ocella were ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 Daily Gossip issued ... a new review on their page. John Colston, Daily Gossip’s ... to Shaun Hadsall’s revolutionizing 14-Day Rapid Fat Loss Plan ... sustain that carbs are healthy at a time when nutritionists ... from highly caloric products. , The diet is based ...
(Date:5/18/2013)... May 18, 2013 Also known as ... increasingly popular weight loss surgery that guarantees patients long-term ... Center wishes to give readers a brief tutorial ... attended medical school at New York City’s Mount Sinai ... Methodist he undertook a fellowship in Minimally Invasive Bariatric ...
(Date:5/18/2013)... May 18 (HealthDay News) -- Children who swallow high-powered ... remove the objects, according to a new study. ... in New Orleans, found that more than 79 percent ... either surgery or an endoscopic procedure, in which a ... tract. Only 21 percent of these cases can be ...
Breaking Medicine News(10 mins):Health News:Clases de Yoga in Buenos Aires, Argentina (Yoga Classes) Now Offered by Sivananda Yoga Vedanta Center 2Health News:Yazsideeffects.com Connects Yaz Side Effects Sufferers With Yaz Side Effects Lawyers 2Health News:Everything You Need to Know About Lap Band Surgery 2Health News:Everything You Need to Know About Lap Band Surgery 3Health News:Swallowing Magnets Can Be Fatal for Children 2
(Date:5/16/2013)... and MECHELEN, Belgium , ... and AbbVie (NYSE: ABBV ) announced today ... include Crohn,s disease.  Galapagos will fund and complete a ... to facilitate rapid progression into Phase 3.  Upon successful ... will pay Galapagos $50 million.  The terms of the ...
(Date:5/16/2013)... RALEIGH, N.C. , May 16, 2013  Today, ... North Carolina House of Representatives recently ... coverage for chemotherapy from charging patients higher out-of-pocket fees ... IV formularies, many of which have more severe side-effects. ... out-of-pocket limit of $300, which will continue to be ...
(Date:5/16/2013)... 2013  Amgen (NASDAQ: AMGN ) will participate ... 21, 2013, at the Sheraton New York Times Square in ... a.m. Eastern Daylight Time. Joseph P. Miletich ... at Amgen, will present at the conference. Live audio of ... Amgen,s website, www.amgen.com , under Investors. A replay of ...
Breaking Medicine Technology:AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3
Cached News: